Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duvivier

Showing results (491-500 of 505) with videos related to

Pageof 51
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 14, 2025
Risk of cancer in people with HIV experiencing varying degrees of immune recovery with sustained virological suppression on antiretroviral treatment for more than 2 years: an international, multicentre, observational cohortWin Min Han, Lene Ryom, Caroline A Sabin, et al.
Plos One|December 19, 2018
Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohortOumar Billa, Mathieu Chalouni, Dominique Salmon, et al.
Radiology|June 26, 2015
MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50-75 Years with Extremely Dense Breasts: The DENSE Trial Study DesignMarleen J Emaus, Marije F Bakker, Petra H M Peeters, et al.
Plos One|January 26, 2019
Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort studySarah Shili-Masmoudi, Philippe Sogni, Victor de Ledinghen, et al.
Radiology|March 4, 2025
The Diagnostic Accuracy of <sup>18</sup>F-FDG PET and <sup>18</sup>F-FES PET for Staging Grade 1-2 Estrogen Receptor-Positive Breast CancerJelijn J Knip, Ramsha Iqbal, Emma C Bonjer, et al.
BMC Infectious Diseases|October 26, 2010
The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010Marc-Arthur Loko, Dominique Salmon, Patrizia Carrieri, et al.
JCO Precision Oncology|October 16, 2024
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With <i>CDKN2A</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry StudyFrancis P Worden, Evan Pisick, Michael Rothe, et al.
BMC Cancer|May 10, 2023
Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial-a study protocolYasmin A Civil, Arlene L Oei, Katya M Duvivier, et al.
The New England Journal of Medicine|November 28, 2019
Supplemental MRI Screening for Women with Extremely Dense Breast TissueMarije F Bakker, Stéphanie V de Lange, Ruud M Pijnappel, et al.
Radiology|March 16, 2021
Supplemental Breast MRI for Women with Extremely Dense Breasts: Results of the Second Screening Round of the DENSE TrialStefanie G A Veenhuizen, Stéphanie V de Lange, Marije F Bakker, et al.
Pageof 51

Showing results (491-500 of 505) with videos related to

Sort By:
Pageof 51
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 14, 2025
Risk of cancer in people with HIV experiencing varying degrees of immune recovery with sustained virological suppression on antiretroviral treatment for more than 2 years: an international, multicentre, observational cohortWin Min Han, Lene Ryom, Caroline A Sabin, et al.
Plos One|December 19, 2018
Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohortOumar Billa, Mathieu Chalouni, Dominique Salmon, et al.
Radiology|June 26, 2015
MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50-75 Years with Extremely Dense Breasts: The DENSE Trial Study DesignMarleen J Emaus, Marije F Bakker, Petra H M Peeters, et al.
Plos One|January 26, 2019
Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort studySarah Shili-Masmoudi, Philippe Sogni, Victor de Ledinghen, et al.
Radiology|March 4, 2025
The Diagnostic Accuracy of <sup>18</sup>F-FDG PET and <sup>18</sup>F-FES PET for Staging Grade 1-2 Estrogen Receptor-Positive Breast CancerJelijn J Knip, Ramsha Iqbal, Emma C Bonjer, et al.
BMC Infectious Diseases|October 26, 2010
The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010Marc-Arthur Loko, Dominique Salmon, Patrizia Carrieri, et al.
JCO Precision Oncology|October 16, 2024
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With <i>CDKN2A</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry StudyFrancis P Worden, Evan Pisick, Michael Rothe, et al.
BMC Cancer|May 10, 2023
Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial-a study protocolYasmin A Civil, Arlene L Oei, Katya M Duvivier, et al.
The New England Journal of Medicine|November 28, 2019
Supplemental MRI Screening for Women with Extremely Dense Breast TissueMarije F Bakker, Stéphanie V de Lange, Ruud M Pijnappel, et al.
Radiology|March 16, 2021
Supplemental Breast MRI for Women with Extremely Dense Breasts: Results of the Second Screening Round of the DENSE TrialStefanie G A Veenhuizen, Stéphanie V de Lange, Marije F Bakker, et al.
Pageof 51